Your browser doesn't support javascript.
loading
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data.
Wilkins, Deidre; Langedijk, Annefleur C; Lebbink, Robert Jan; Morehouse, Christopher; Abram, Michael E; Ahani, Bahar; Aksyuk, Anastasia A; Baraldi, Eugenio; Brady, Tyler; Chen, Albert Tian; Chi, Hsin; Choi, Eun Hwa; Cohen, Robert; Danilenko, Daria M; Gopalakrishnan, Vancheswaran; Greenough, Anne; Heikkinen, Terho; Hosoya, Mitsuaki; Keller, Christian; Kelly, Elizabeth J; Kragten-Tabatabaie, Leyla; Martinón-Torres, Federico; de Los Santos, Abiel Homero Mascareñas; Nunes, Marta C; Palomino, María Angélica; Papenburg, Jesse; Pernica, Jeffrey M; Richmond, Peter; Stein, Renato T; Tuffy, Kevin M; Verwey, Charl; Esser, Mark T; Tabor, David E; Bont, Louis J.
Afiliação
  • Wilkins D; Translational Medicine, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Langedijk AC; Division of Paediatric Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands.
  • Lebbink RJ; Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, Netherlands.
  • Morehouse C; Bioinformatics, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Abram ME; Translational Medicine, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Ahani B; Bioinformatics, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Aksyuk AA; Translational Medicine, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Baraldi E; Woman's and Child's Health, Neonatal Intensive Care Unit, University of Padova, Padova, Italy; Institute of Pediatric Research, Città della Speranza, Padova, Italy.
  • Brady T; Translational Medicine, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Chen AT; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Biological and Biomedical Sciences, Harvard University, Cambridge, MA, USA.
  • Chi H; Department of Paediatrics, MacKay Children's Hospital, Taipei, Taiwan.
  • Choi EH; Department of Pediatrics, Seoul National University Children's Hospital, Seoul, South Korea.
  • Cohen R; Université Paris XII, Créteil, FranceAssociation Clinique et Thérapeutique Infantile du Val-de-Marne (ACTIV), Créteil, France; Clinical Research Center, Centre Hospitalier Intercommunal de Créteil (CHIC), Créteil, France.
  • Danilenko DM; Smorodintsev Research Institute of Influenza, Saint Petersburg, Russia.
  • Gopalakrishnan V; Bioinformatics, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Greenough A; Department of Women and Children's Health, King's College London, London, UK; ReSViNET foundation, Zeist, Netherlands.
  • Heikkinen T; ReSViNET foundation, Zeist, Netherlands; Department of Pediatrics, University of Turku, Turku, Finland; Department of Pediatrics, Turku University Hospital, Turku, Finland.
  • Hosoya M; School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Keller C; University Hospital Giessen and Marburg, Marburg, Germany.
  • Kelly EJ; Translational Medicine, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Kragten-Tabatabaie L; ReSViNET foundation, Zeist, Netherlands; Julius Clinical, Zeist, Netherlands.
  • Martinón-Torres F; ReSViNET foundation, Zeist, Netherlands; Translational Paediatrics and Infectious Diseases, Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria
  • de Los Santos AHM; Department of Pediatrics, Division of Infectious Diseases, Jose Eluterio Gonzalez Hospital Universitario, Monterrey, Mexico.
  • Nunes MC; ReSViNET foundation, Zeist, Netherlands; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology, National Research Foundation, South African Research Chair Ini
  • Palomino MA; Hospital Roberto del Río, Santiago, Chile.
  • Papenburg J; Department of Pediatrics, McGill University Health Centre, Montreal, QC, Canada.
  • Pernica JM; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.
  • Richmond P; Division of Pediatrics, School of Medicine, University of Western Australia, Perth, WA, Australia.
  • Stein RT; ReSViNET foundation, Zeist, Netherlands; Pontificia Universidade Catolica de Rio Grande do Sul, Porto Alegre, Brazil.
  • Tuffy KM; Translational Medicine, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Verwey C; Department of Paediatrics and Child Health, School of Clinical Medicine and South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Esser MT; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Electronic address: mark.esser@astrazeneca.com.
  • Tabor DE; Translational Medicine, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Bont LJ; Department of Paediatrics, University Medical Centre Utrecht, Utrecht, Netherlands; ReSViNET foundation, Zeist, Netherlands.
Lancet Infect Dis ; 23(7): 856-866, 2023 Jul.
Article em En | MEDLINE | ID: mdl-36940703
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / COVID-19 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Infant Idioma: En Ano de publicação: 2023 Tipo de documento: Article